Screener
CG Oncology CGON Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
| Assets | June 30, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Accounts payable | $12,727 | $5,714 |
| Operating lease liabilities, current portion | 985 | 915 |
| Accrued expenses and other current liabilities | 33,528 | 24,207 |
| Total current liabilities | 47,240 | 30,836 |
| Long-term debt | 3,000 | 3,000 |
| Operating lease liabilities, net of current portion | 4,834 | 3,106 |
| Deferred tax liability | 307 | 307 |
| Other liabilities | 1,156 | 1,741 |
Item 1. Financial Statements.
FAQ
- What is CG Oncology's total current liabilities?
- CG Oncology (CGON) reported total current liabilities of $47.24M in Q2 2026.
- How has CG Oncology's total current liabilities changed year-over-year?
- CG Oncology's total current liabilities increased by 55.5% year-over-year, from $30.38M to $47.24M.
- What is the long-term trend for CG Oncology's total current liabilities?
- Over 2 years (2023 to 2025), CG Oncology's total current liabilities has grown at a 47.1% compound annual growth rate (CAGR), from $14.25M to $30.84M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about CG Oncology's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude